Type 2 Diabetes Clinical Trials in New Haven, Connecticut

4 studies are recruiting for type 2 diabetes in New Haven, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

    This study will collect sensor data in subjects with T1D or T2D, 2-80 years of age.

    Stage
    Not phased
    Ages
    2 to 80
    Site
    Yale University School of Medicine, New Haven, Connecticut
    Locations
    18 in total
    Run by
    Medtronic MiniMed, Inc.

    See if you can join NCT07864168 on ClinicalTrials.gov

  2. A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

    The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.

    Stage
    Phase 3
    Ages
    10 to 17
    Site
    Yale Diabetes Research, New Haven, Connecticut
    Locations
    51 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06739122 on ClinicalTrials.gov

  3. Ultrasound Effects on Glycemic Control in T2DM

    This is an open label, exploratory pilot study that will assess the effects of dual site focused pulsed ultrasound treatment on glycemic parameters in subjects with T2DM.

    Stage
    Not phased
    Ages
    21 to 75
    Site
    Yale-New Haven Hospital, New Haven, Connecticut
    Run by
    Yale University

    See if you can join NCT05354947 on ClinicalTrials.gov

  4. Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

    This non-blinded, non-randomized pre-post study will examine the impact of providing CGM sensors free of charge to adult patients of Fair Haven Community Health Care with poorly controlled type 2 diabetes on glycemic control and quality of life.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Fair Haven Community Health Care (FHCHC), New Haven, Connecticut
    Run by
    Yale University

    See if you can join NCT06658067 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.